Overview

Dexmedetomidine in IVRA

Status:
Completed
Trial end date:
2021-06-20
Target enrollment:
Participant gender:
Summary
A prospective randomized controlled double-blinded study will be conducted on 90 patients assigned randomly into three equal groups,
Phase:
Phase 4
Details
Lead Sponsor:
Menoufia University
Collaborators:
Ayman Ahmed Radi
Mohamed Abodief Mohamed Ahmed
Sadik Abdel Maseeh Sadik
Treatments:
Dexmedetomidine
Lidocaine